LANA HARRISON: Open Payments
NPI 1821774670 · LA GRANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 68 payments from 8 companies in 2025. Trend: 2023 $355 · 2024 $405 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $389 |
| Amgen Inc. | 25 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $139 |
| E.R. Squibb & Sons, L.L.C. | 2 | $129 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $95 |
| Alnylam Pharmaceuticals Inc. | 2 | $73 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Boston Scientific Corporation | 1 | $23 |
Products named: LEQVIO, REPATHA, Kerendia, CAMZYOS, LifeVest, ONPATTRO, AMVUTTRA, VERQUVO.
Industry payments across TX — which companies pay providers there.
